» Articles » PMID: 28303897

Synergistic Efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone Combination Against MDR Bacterial Strains

Overview
Journal Sci Rep
Specialty Science
Date 2017 Mar 18
PMID 28303897
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of efflux systems and the formation of biofilm are majorly adapted by microbes to resist antimicrobial agents. PPEF (bisbenzimidazole) targeting topoisomerase IA is observed to be an effective bactericidal agent against both Gram-positive and Gram-negative bacterial strains and thus can be developed as potent broad-spectrum antibiotic against MDR strains. PPEF treatment did not cause target specific mutation instead it leads to up-regulation of efflux gene in E. coli K12 as a mechanism of resistance. Microscopy, fluorescence spectroscopy and flow cytometry result demonstrate higher accumulation of PPEF in efflux gene deleted E. coli K12 mutants, and also suggest that Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP), resist the efflux of PPEF, and thus increases efficacy of PPEF. Herein, we report, PPEF and CCCP synergistically killed the persistent bacterial cells, which are not killed by PPEF alone. The above two compounds together inhibited biofilm formation, eradicate preformed biofilms and kills the biofilm cells of P. aeruginosa. PPEF and CCCP together reduced bacterial load of E. coli ATCC25922 by 6 log in neutropenic thigh infection model of balb/c mice. Present study suggests that combination therapy could be a promising antimicrobial strategy to handle MDR pathogenic strains.

Citing Articles

Unraveling topoisomerase IA gate dynamics in presence of PPEF and its preclinical evaluation against multidrug-resistant pathogens.

Maurya V, Singh R, Singh R, Pandey S, Yadav P, Parashar P Commun Biol. 2023; 6(1):195.

PMID: 36807602 PMC: 9938908. DOI: 10.1038/s42003-023-04412-1.


An antibacterial compound pyrimidomycin produced by Streptomyces sp. PSAA01 isolated from soil of Eastern Himalayan foothill.

Das P, Kundu S, Maiti P, Mandal S, Sahoo P, Mandal S Sci Rep. 2022; 12(1):10176.

PMID: 35715695 PMC: 9206078. DOI: 10.1038/s41598-022-14549-4.


Effect of new carbonyl cyanide aromatic hydrazones on biofilm inhibition against methicillin resistant .

Lu X, Zhang Z, Xu Y, Lu J, Tang W, Zhang J RSC Adv. 2022; 10(30):17854-17861.

PMID: 35515581 PMC: 9053579. DOI: 10.1039/d0ra03124k.


Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.

Adeniji A, Knoll K, Loots D Appl Microbiol Biotechnol. 2020; 104(13):5633-5662.

PMID: 32372202 DOI: 10.1007/s00253-020-10606-y.


Gram-negative synergy and mechanism of action of alkynyl bisbenzimidazoles.

Chamberlin J, Story S, Ranjan N, Chesser G, Arya D Sci Rep. 2019; 9(1):14171.

PMID: 31578425 PMC: 6775084. DOI: 10.1038/s41598-019-48898-4.

References
1.
Reimer L, Stratton C, Reller L . Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother. 1981; 19(6):1050-5. PMC: 181606. DOI: 10.1128/AAC.19.6.1050. View

2.
Stiefel P, Schmidt-Emrich S, Maniura-Weber K, Ren Q . Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide. BMC Microbiol. 2015; 15:36. PMC: 4337318. DOI: 10.1186/s12866-015-0376-x. View

3.
Silver L . Challenges of antibacterial discovery. Clin Microbiol Rev. 2011; 24(1):71-109. PMC: 3021209. DOI: 10.1128/CMR.00030-10. View

4.
Mu H, Tang J, Liu Q, Sun C, Wang T, Duan J . Potent Antibacterial Nanoparticles against Biofilm and Intracellular Bacteria. Sci Rep. 2016; 6:18877. PMC: 4700437. DOI: 10.1038/srep18877. View

5.
Peeters E, Nelis H, Coenye T . In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother. 2009; 64(4):801-9. DOI: 10.1093/jac/dkp253. View